SCHEDULE: Smead Capital Management Discloses Macerich Stake
Beneficial Ownership Filing (Schedule 13G)
Smead Capital Management, Inc., along with William W. Smead and Cole W. Smead, has filed a Schedule 13G, reporting beneficial ownership of 12,155,332.57 shares of Macerich Co. common stock, representing 4.74% of the class.
Summary
- Smead Capital Management, Inc., William W. Smead, and Cole W. Smead have jointly filed a Schedule 13G, indicating their beneficial ownership of Macerich Co. common stock.
- The total number of shares beneficially owned by these reporting persons is 12,155,332.57.
- This ownership stake represents 4.74% of the total class of Macerich Co. common stock.
- The reporting persons possess sole voting power and sole dispositive power over these shares.
- The filing is an amendment (Amendment No. 4) to a previous filing, with the event date requiring this statement being March 31, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it represents a significant investment stake by an established investment firm, but does not contain operational or financial performance updates.
Positives
- Smead Capital Management, Inc. and its associated individuals have taken a significant stake in Macerich Co., suggesting confidence in the company's future prospects.
- The reporting persons hold sole voting and dispositive power, indicating a clear investment strategy and control over their holdings.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. It is a disclosure of current ownership.
Industry Context
StockSavvy.ai notes that this Schedule 13G filing by Smead Capital Management indicates a significant investment in the retail real estate sector, specifically in a Real Estate Investment Trust (REIT) like Macerich Co. Such filings often signal a belief in the underlying asset value or potential for strategic changes within the company.
Stakeholder Impact
- Shareholders: The filing may signal increased institutional interest in Macerich Co., potentially influencing market perception and share price.
- Management: The significant stake held by Smead Capital Management may lead to increased engagement or scrutiny from the reporting persons regarding company strategy and performance.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Date of Event Which Requires Filing of this Statement |
| 04/22/2026 | Date of Signatures on the Schedule 13G and Joint Filing Statement |
Recommendation
holdThis filing is a disclosure of ownership and does not provide performance data or strategic updates for Macerich Co. Therefore, a 'hold' recommendation is appropriate based solely on this information, pending further analysis of the company's financial health and operational performance.
Keywords
Macerich Co, Schedule 13G, Smead Capital Management, William W. Smead, Cole W. Smead, Common Stock, Beneficial Ownership, SEC Filing, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.